1-50 of 86
Keywords: cirrhosis
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2021) 135 (24): 2709–2728.
Published: 15 December 2021
...Hui-Chun Huang; Ming-Hung Tsai; Ching-Chih Chang; Chon Kit Pun; Yi-Hsiang Huang; Ming-Chih Hou; Fa-Yauh Lee; Shao-Jung Hsu Liver cirrhosis and portal hypertension is the end of chronic liver injury with hepatic, splanchnic and portosystemic collateral systems dysregulation. Liver injury...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2020) 134 (23): 3137–3158.
Published: 07 December 2020
... License 4.0 (CC BY) . Open access for this article was enabled by the participation of University of New South Wales in an all-inclusive Read and Publish pilot with Portland Press and the Biochemical Society under a transformative agreement with CAUL. cirrhosis renin-angiotensin system...
Articles
Clin Sci (Lond) (2020) 134 (16): 2189–2201.
Published: 26 August 2020
... resistance. The end result of progressive fibrosis, cirrhosis, is associated with significant morbidity and mortality as well as tremendous economic burden. Fibrosis can be conceptualized as an aberrant wound healing response analogous to a chronic ankle sprain that is driven by chronic liver injury commonly...
Articles
Clin Sci (Lond) (2020) 134 (16): 2117–2135.
Published: 21 August 2020
... groups of patients, an IR in almost all cirrhotic patients can be observed, compared with a control group. Additionally, it has been demonstrated that IR in cirrhosis is linked to a decreased peripheral (muscle) glucose uptake rather than an increased liver glucose production. The homoeostasis model...
Articles
Clin Sci (Lond) (2020) 134 (15): 2055–2073.
Published: 10 August 2020
...@vghtpe.gov.tw ) 16 04 2020 28 07 2020 28 07 2020 29 07 2020 © 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2020 apoptosis ascites chronic hepatorenal syndrome cirrhosis oxidative stress renal vasoconstriction Patients...
Articles
Clin Sci (Lond) (2020) 134 (11): 1219–1242.
Published: 05 June 2020
... © 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2020 cirrhosis diabetes angiogenesis portosystemic collaterals insulin The authors of the original article “Insulin reverses the major portal hypertension-related derangements in rats...
Articles
Clin Sci (Lond) (2019) 133 (6): 741–760.
Published: 19 March 2019
... important in PBC pathogenesis. Activation of these cells initiates and perpetuates bile duct damage in PBC patients, leading to intrahepatic cholestasis, hepatic damage, liver fibrosis, and eventually cirrhosis or even liver failure. Taken together, the body of accumulated clinical and experimental evidence...
Articles
Clin Sci (Lond) (2019) 133 (3): 465–481.
Published: 12 February 2019
... muscle alteration in CLD. We next describe recent literature on muscle wasting in cirrhosis and liver transplantation. We then discuss the implication of skeletal muscle compartment in non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), focusing on plausible metabolic...
Articles
Clin Sci (Lond) (2018) 132 (22): 2391–2405.
Published: 19 November 2018
...I-Fang Hsin; Hui-Chun Huang; Ching-Chih Chang; Shao-Jung Hsu; Fa-Yauh Lee; Teh-Ia Huo; Chiao-Lin Chuang; Ming-Chih Hou; Shou-Dong Lee Liver cirrhosis is accompanied by increased intrahepatic resistance and angiogenesis-related portosystemic collaterals formation. Diabetic patients suffer from...
Articles
Clin Sci (Lond) (2018) 132 (12): 1341–1343.
Published: 28 June 2018
...Audrey Payancé; Pierre-Emmanuel Rautou Data on the consequences of cirrhosis regression on portal hypertension and on splanchnic and systemic hemodynamic are scarce. Previous studies have reported a decrease in hepatic venous pressure gradient following antiviral treatment in patients...
Articles
Clin Sci (Lond) (2017) 131 (15): 2059–2062.
Published: 20 July 2017
.... and Noureddin M. ( 2016 ) Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The Multiethnic Cohort . Hepatology 64 , 1969 – 1977 11 Blachier M. , Leleu H. , Peck-Radosavljevic M. , Valla D.-C. and Roudot-Thoraval F...
Articles
Clin Sci (Lond) (2012) 123 (12): 669–680.
Published: 10 August 2012
... and the disarrangement in the hepatic microcirculation. NASH-cirrhosis with hyperleptinaemia was induced in lean rats by feeding with an HF/MCD (high-fat/methionine-choline-deficient) diet. Portal haemodynamics, various substances, protein and mRNA expression and PUFA (polyunsaturated fatty acid) composition were...
Articles
Clin Sci (Lond) (2012) 123 (4): 225–239.
Published: 24 April 2012
... to the pathophysiology of portal hypertension in cirrhosis. Although the intrahepatic circulation in cirrhosis is hypercontractile in response to AngII, resulting in increased hepatic resistance, the splanchnic vasculature is hyporesponsive, promoting the development of the hyperdynamic circulation that characterizes...
Articles
Clin Sci (Lond) (2011) 120 (7): 285–286.
Published: 13 December 2010
...Pietro Invernizzi HCV (hepatitis C virus) represents one of the major health problems worldwide, as almost 170 million people are infected and most of these develop a chronic disease, often with the progression to cirrhosis and its complications. In the present issue of Clinical Science , Iwata...
Articles
Clin Sci (Lond) (2011) 120 (7): 287–296.
Published: 13 December 2010
... HCV (hepatitis C virus)-associated cirrhosis represents a major indication for liver transplantation. Bile acids contribute to hepatic stellate cell activation as a key event in fibrogenesis. The aim of the present study was to investigate the role of bile acids and polymorphisms in bile acid level...
Articles
Clin Sci (Lond) (2011) 120 (5): 183–193.
Published: 19 November 2010
... serum miRNAs as biomarkers for liver pathologies. Real-time qPCR (quantitative PCR)-based TaqMan MicroRNA arrays were first employed to profile miRNAs in serum pools from patients with HCC (hepatocellular carcinoma) or LC (liver cirrhosis) and from healthy controls. Five miRNAs (i.e. miR - 885 - 5p...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2010) 119 (10): 431–436.
Published: 05 August 2010
... hepatitis, n =71; autoimmune disease, n =18; alcohol-induced liver disease, n =3; or elevated liver enzymes of unknown origin, n =31) and 45 with cirrhosis. Circulating adiponectin levels were significantly lower in patients with NAFLD in comparison with patients with other chronic liver disease (4.8±3.5...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2010) 119 (7): 283–292.
Published: 25 June 2010
...Fabiano E. Xavier; Javier Blanco-Rivero; Esther Sastre; Lina Badimón; Gloria Balfagón Our present study examines, in mesenteric resistance arteries, possible vasodilation alterations, and the role of NO and COX (cyclo-oxygenase) derivatives, in cirrhosis. The vasodilator response to acetylcholine...
Articles
Clin Sci (Lond) (2010) 119 (1): 45–55.
Published: 07 April 2010
... for 1 week on the hepatic microcirculation of cirrhotic rats. Cirrhosis was induced by bile duct ligation with sham-operated rats serving as normal controls. Intrahepatic resistance was evaluated by in situ liver perfusion. Expression of phospho-eNOS (endothelial NO synthase), iNOS (inducible...
Articles
Clin Sci (Lond) (2009) 117 (11): 375–386.
Published: 14 September 2009
...–angiotensin system) components and the effects of Ang-(1–7) were examined in rat HSCs (hepatic stellate cells). In human patients with cirrhosis, both plasma Ang-(1–7) and AngII concentrations were markedly elevated ( P <0.001). Non-cirrhotic patients with hepatitis C had elevated Ang-(1–7) levels compared...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2009) 116 (12): 851–859.
Published: 14 May 2009
...Simonetta Genovesi; Daniela M. Prata Pizzala; Massimo Pozzi; Laura Ratti; Maria Milanese; Federico Pieruzzi; Antonio Vincenti; Andrea Stella; Giuseppe Mancia; Marco Stramba-Badiale A prolongation of QT interval has been shown in patients with cirrhosis and it is considered as part of the definition...
Articles
Clin Sci (Lond) (2009) 116 (1): 71–79.
Published: 28 November 2008
...Ying-Ying Yang; Yi-Tsau Huang; Kuei-Chuan Lee; Fa-Yauh Lee; Tzung-Yan Lee; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee Liver cirrhosis is characterized by increased IHR (intrahepatic resistance) and lipid peroxidation, and decreased antioxidative defence. The present study investigates the effects...
Articles
Clin Sci (Lond) (2007) 112 (10): 533–542.
Published: 12 April 2007
...Ying-Ying Yang; Han-Chieh Lin; Yi-Tsau Huang; Tzung-Yan Lee; Ming-Chih Hou; Ying-Wen Wang; Fa-Yauh Lee; Shou-Dong Lee Recent studies have shown that the activated endocannabinoid system participates in the increase in IHR (intrahepatic resistance) in cirrhosis. The increased hepatic production...
Articles
Clin Sci (Lond) (2007) 112 (5): 265–280.
Published: 01 February 2007
... cell, significant contributions may occur from other cell lineages, including those from distant sites such as bone marrow stem cells. cirrhosis collagen fibrosis hepatic stellate cell inflammation liver myofibroblast Fibrosis of the liver and its end stage, cirrhosis, represents...
Articles
Clin Sci (Lond) (2007) 112 (3): 141–155.
Published: 03 January 2007
...Ulrich Spengler; Jacob Nattermann HCV (hepatitis C virus) has a high propensity to persist and to cause chronic hepatitis C, eventually leading to cirrhosis. Since HCV itself is not cytopathic, liver damage in chronic hepatitis C is commonly attributed to immune-mediated mechanisms. HCV proteins...
Articles
Clin Sci (Lond) (2004) 107 (5): 425–434.
Published: 26 October 2004
...Brindhesha RASARATNAM; Nathan CONNELLY; Jaye CHIN-DUSTING Abnormal vascular tone is responsible for many of the complications seen in cirrhosis making the identification of the pathophysiology of abnormal dilatation a major focus in hepatology research. The study of abnormal vascular tone...
Articles
Clin Sci (Lond) (2004) 106 (1): 27–34.
Published: 01 January 2004
...Pietro PANTALEO; Fabio MARRA; Francesco VIZZUTTI; Saura SPADONI; Giovanni CIABATTONI; Claudio GALLI; Giorgio LA VILLA; Paolo GENTILINI; Giacomo LAFFI Advanced cirrhosis is associated with reduced platelet function and altered renal function and sodium handling. Arachidonic acid (AA) metabolites...
Articles
Clin Sci (Lond) (2003) 105 (3): 373–382.
Published: 01 September 2003
... cirrhosis and controls. Results were compared with histology, hepatic expression of tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3, procollagen types I and IV, laminin, and with circulating protein levels of hyaluronate, TIMP-1 and -2 and MMP proenzymes, as measured by ELISA. The impact...
Articles
Clin Sci (Lond) (2003) 105 (1): 1–8.
Published: 01 July 2003
... cirrhosis vasopressin Clinical Science (2003) 105, 1 8 (Printed in Great Britain) 1 R E V I E W Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis James Walter FERGUSON , George THERAPONDOS , David E NEWBY and Peter Clive HAYES Department of Medicine, Royal Infirmary...
Articles
Clin Sci (Lond) (2001) 101 (6): 651–657.
Published: 20 November 2001
... is facilitated by plasmin. In the ascitic fluid of patients with cirrhosis, there is massive cleavage of high- M r kininogen and activation of fibrinolysis, but bradykinin has never been measured directly. In the ascitic fluid of 24 patients with cirrhosis, we measured bradykinin-(1-9)-nonapeptide levels by RIA...
Articles
Clin Sci (Lond) (2001) 101 (6): 621–628.
Published: 29 October 2001
...Florence WONG; Samuel SIU; Peter LIU; Laurence M. BLENDIS Subtle cardiac abnormalities have been described in patients with cirrhosis. Natriuretic peptide hormones have been reported to be sensitive markers of early cardiac disease. We postulate that plasma levels of N-terminal pro-atrial...
Articles
Clin Sci (Lond) (2000) 99 (2): 159–160.
Published: 17 July 2000
...Giovambattista DESIDERI; Claudio FERRI Correspondence : Dr G Desideri (e-mail gbdesi@freemail.it ). 13 12 1999 The Biochemical Society and the Medical Research Society © 2000 2000 chronic hepatitis cirrhosis vascular endothelial growth factor 159Clinical Science (2000...
Articles
Clin Sci (Lond) (2000) 98 (4): 419–425.
Published: 08 March 2000
...Sun-Sang WANG; Fa-Yauh LEE; Che-Chang CHAN; Rei-Hwa LU; Yee CHAO; Han-Chieh LIN; Shwu-Ling WU; Yang-Te TSAI; Shou-Dong LEE To delineate the clinical roles of plasma cytokine or endotoxin levels in the natural course of infection in patients with decompensated cirrhosis, 66 cirrhotic patients were...
Articles
Clin Sci (Lond) (1999) 97 (3): 313–318.
Published: 21 July 1999
...Dominique PATERON; Frédéric OBERTI; Pascale LEFILLIATRE; Nary VEAL; Khalid A. TAZI; Philippe SOGNI; Odile POIREL; Jörg HELLER; Richard MOREAU; Paul CALES; Didier LEBREC In cirrhosis there is a hyperdynamic circulation, which occurs mainly in the systemic and splanchnic regions. Using isolated...
Articles
Clin Sci (Lond) (1999) 97 (3): 259–267.
Published: 15 July 1999
...Florence WONG; Peter LIU; Lesley LILLY; Arieh BOMZON; Laurence BLENDIS The aim of this study was to assess the relationship between subtle cardiovascular abnormalities and abnormal sodium handling in cirrhosis. A total of 35 biopsy-proven patients with cirrhosis with or without ascites and 14 age...
Articles
Clin Sci (Lond) (1999) 96 (5): 475–481.
Published: 14 April 1999
...Panagiotis VLAVIANOS; Padraik MAC MATHUNA; Roger WILLIAMS; David WESTABY We investigated the haemodynamic response to volume depletion and subsequent repletion in patients with cirrhosis and portal hypertension. Twelve patients with compensated cirrhosis and portal hypertension were included...
Articles
Clin Sci (Lond) (1999) 96 (5): 467–474.
Published: 25 March 1999
...Florence WONG; Arieh BOMZON; Johane ALLARD; Peter LIU; Laurence BLENDIS Systemic arterial vasodilatation has been implicated in the pathogenesis of sodium retention in cirrhosis. Hydrophobic bile acids, which have vasodilatory actions, may be involved. Ursodeoxycholic acid, a hydrophilic bile acid...
Articles
Clin Sci (Lond) (1998) 95 (4): 505–511.
Published: 01 October 1998
...Patrick W. F. HADOKE; John F. DILLON; Timothy G. JOHN; Simon W. WALKER; Peter C. HAYES; Brent C. WILLIAMS 1. Impaired vasoconstriction in animals with cirrhosis is maintained in isolated vessels in vitro , indicating an intrinsic alteration in function or structure of the cells in the vascular wall...
Articles
Clin Sci (Lond) (1998) 94 (4): 367–371.
Published: 01 April 1998
... Society and the Medical Research Society 1998 cirrhosis octreotide portal hypertension portal hypertensive gastropathy Clinical Science (1998) 94,367-371 (Printed in Great Britain) 361 Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy...
Articles
Clin Sci (Lond) (1997) 93 (3): 219–225.
Published: 01 September 1997
...]. In 1991, Vallance and Moncada [4] proposed that the increased synthesis and release of the vascular endo- thelium-derived vasodilator. nitric oxide (NO), induced directly by endotoxin or indirectly by cyto- kines, could account for the peripheral cardio- vascular abnormalities of cirrhosis [4]. Although...
Articles
Clin Sci (Lond) (1997) 92 (5): 433–443.
Published: 01 May 1997
... may be a treatable precipitant of renal failure in cirrhosis. Renal perfusion should be optimized by ensuring that the blood pressure and systemic haemodynamics are adequate, and that if renal venous pressure is elevated, due to tense ascites, it is alleviated. 4. The prognosis of hepatorenal syndrome...
Articles
Clin Sci (Lond) (1997) 92 (1): 59–62.
Published: 01 January 1997
... with essential hypertension, 12 with heart failure, 10 with ascites due to cirrhosis, 12 with chronic renal failure, four with hypoxia due to chronic obstructive pulmonary disease and 12 control subjects. 3. Plasma levels (mean ± SEM) in patients with essential hypertension (16.3 ± 1.9 pmol/l), congestive heart...
Articles
Clin Sci (Lond) (1996) 91 (1): 29–33.
Published: 01 July 1996
... administration. 4. This study shows that in rats with cirrhosis, pentoxifylline induces a decrease in both portal pressure and plasma tumour necrosis factor-α concentrations. These reductions were not correlated however. 25 3 1996 1 4 1996 © 1996 The Biochemical Society and the Medical Research...
Articles
Clin Sci (Lond) (1995) 89 (3): 227–232.
Published: 01 September 1995
...Samuel S. Lee; Jung-Min Pak; Shaun M. Medlicott; Arieh Bomzon 1. There is currently considerable interest in the role of locally produced vasodilators such as nitric oxide and adenosine in the pathogenesis of the peripheral vasodilatation of cirrhosis. However, the signal transduction pathways...
Articles
Clin Sci (Lond) (1994) 87 (3): 329–335.
Published: 01 September 1994
...Alastair MacGilchrist; Kathrine J. Craig; Peter C. Hayes; Allan D. Cumming 1. Previous studies have documented activation of protease enzymes, such as the plasma kallikrein-kinin system, in hepatic cirrhosis. Increased plasma kinin generation could contribute to pathological systemic vasodilatation...
Articles
Clin Sci (Lond) (1994) 87 (3): 357–362.
Published: 01 September 1994
...M. H. Davies; L. Klovrza; R. H. Waring; E. Elias 1. Fasting levels of plasma cysteine, plasma sulphate and the plasma cysteine/sulphate ratio were measured in patients with primary biliary cirrhosis and compared with those in patients with other liver disease, general intensive therapy unit...
Articles
Clin Sci (Lond) (1994) 86 (5): 489–495.
Published: 01 May 1994
...David A. Lomas 1. The Z deficiency variant of α 1 -antitrypsin predisposes the homozygote to early-onset panlobular emphysema and results in the accumulation of antitrypsin within the hepatocyte, which leads to hepatocellular damage and cirrhosis. The mechanism of this accumulation has been shown...
Articles
Clin Sci (Lond) (1994) 86 (4): 447–451.
Published: 01 April 1994
..., such as hepatocellular carcinoma or liver cirrhosis caused by chronic viral hepatitis, and correlated with reduced albumin levels in these conditions, indicating that the liver is the site of phosphoinositol-specific phospholipase D synthesis and that phosphoinositol-specific phospholipase D may be used as an additional...
Articles
Clin Sci (Lond) (1994) 86 (2): 203–208.
Published: 01 February 1994
...Alison Calver; Adam Harris; J. Douglas Maxwell; Patrick Vallance 1. Nitric oxide (NO) is a potent endogenous vasodilator and plays a role in the control of resting vascular tone. Patients with cirrhosis have a hyperdynamic circulation with reduced blood pressure and decreased peripheral resistance...
Articles
Clin Sci (Lond) (1993) 84 (5): 525–529.
Published: 01 May 1993
...David J. Leehey 1. Decreased pressor sensitivity to angiotensin II occurs in cirrhosis, but the mechanism remains unclear. 2. Angiotensin II dose-response studies were performed in conscious, chronically instrumented cirrhotic and control rats, and angiotensin II concentration-response studies were...